Table 4.

Chalder fatigue score reductions.

* Indicates p < 0.05 over Baseline	Oxaloacetate		Improvement over baseline	Control		Improvement over baseline
	Baseline	End		Baseline	End
Chalder fatigue score, all participants	9.1	6.6	27% ***	8.5	7.1	17% *
Chalder fatigue score, trial completed participants	9.1	6.2	32%*** T (over control)	8.1	7.0	14%
CFS, N of enhanced responders >25% improvement		17/42	40.5% * (over control)		8/40	20%
OAA enhanced responders % fatigue improvement			63% ***
CFS, McNemar’s shift analysis, full set P value			p = 0.0039 ***			P = 0.1094
McNemar’s shift analysis, completed participants P			p = 0.0039 ***			P = 0.4531